FDA approves a 76-mm version of Abbott’s Esprit BTK resorbable scaffold system for patients with CLTI. The longer scaffold is intended to reduce the number of devices needed to treat long BTK lesions ...

Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.

Xeltis announced the official start of the European commercialization of aXess vascular access device for patients requiring hemod ...

Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...

HistoSonics announced that it has received approval in Europe for its Edison system, enabling the commercialization of the ...

The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announ ...

Vesalio announced the appointment of Greg Cook as Chief Commercial Officer, responsible for leading the company’s commercial ...

Egg Medical, a developer of enhanced radiation protection devices (ERPDs) for interventional procedures, announced the launch ...

Stereotaxis announced that it has completed its previously announced acquisition of Robocath, a Rouen, France-based developer ...

Gore & Associates announced that the FDA approved updated labeling for the Gore Excluder abdominal aortic aneurysm (AAA) ...

Endologix LLC announced 36-month results from the DETOUR2 clinical trial evaluating percutaneous transmural arterial bypass ...